Viskari, Hanna
Oikarinen, Sami
Hoppu, Sanna
Vuorinen, Tytti
Huhtala, Heini
Toppari, Jorma
Veijola, Riitta
Ilonen, Jorma
Knip, Mikael
Hyöty, Heikki
Article History
Received: 23 May 2017
Accepted: 10 July 2017
First Online: 2 September 2017
Data availability
: The data that support the findings of this study are available on reasonable request from the author, HV.
: The recruitment of study participants and collection of stool samples in the DIPP study was funded by grants from JDRF, Sigrid Juselius Foundation, Reino Lahtikari Foundation, the Diabetes Research Foundation and the Academy of Finland. The oral polio vaccine (Polio Sabin) was provided by SB Biologicals, Rixensart, Belgium. The study sponsors were not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication
: HHy and MK are minor shareholders (< 5%) in Vactech, a small biotech company developing picornavirus vaccines. There are no other potential conflicts of interest relevant to this article.
: HV, SO, JI, RV, TV, JT, MK and HHy made substantial contributions to the study design, participated in the laboratory and carried out data analysis and interpretation. SH participated in the study design, and recruited and vaccinated the study population. HHu participated in the statistical analyses of the data. All authors helped to draft the manuscript, and read and approved the final version. HHy and MK are the guarantors of this work.